Artificial Intelligence or Tumor Biology to Predict Survival After Resection of Colorectal Liver Metastases? Yoshikuni KawaguchiAnish J. JainJean-Nicolas Vauthey ASO Perspectives 21 February 2023 Pages: 3161 - 3162
Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut Back Mark B. FariesGiorgos Karakousis ASO Perspectives 22 February 2023 Pages: 3163 - 3165
Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study Stephanie Downs-CannerElizabeth A. Mittendorf ASO Perspectives 10 March 2023 Pages: 3166 - 3169
A Ghostwriter for the Masses: ChatGPT and the Future of Writing Asha Zimmerman Global Health Services Research 08 April 2023 Pages: 3170 - 3173
ChatGPT, Large Language Models, and Generative AI as Future Augments of Surgical Cancer Care A. N. Kothari Global Health Services Research 13 April 2023 Pages: 3174 - 3176
HIPEC in the Consolidation Setting: A Consolation Prize for Chemorefractory Ovarian Cancer? Thanh H. Dellinger Peritoneal Surface Malignancy 22 February 2023 Pages: 3177 - 3179
Accepting Our Technical Limitations: Intraoperative Bile Duct Margin in Perihilar Cholangiocarcinoma Reflects Disease Biology Seth J. ConcorsRebecca A. Snyder Hepatobiliary Tumors 03 February 2023 Pages: 3180 - 3181
Modeling the Prediction of Early Treatment Failure After Hepatectomy for Colorectal Liver Metastases Seth ConcorsAntony HaddadJean Nicolas Vauthey Hepatobiliary Tumors 23 March 2023 Pages: 3182 - 3183
Editorial on: Moving Beyond Anatomic Criteria for Resectability: Validation of the Anatomical and Biological Definitions of Borderline Resectable Pancreatic Cancer According to the 2017 International Consensus for Survival and Recurrence in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Upfront Surgery Alessandro PanicciaAmer Zureikat Pancreatic Tumors 27 February 2023 Pages: 3184 - 3185
Incremental Improvements in the Ability to Distinguish High-Risk Intraductal Papillary Mucinous Neoplasms Michael E. Egger Pancreatic Tumors 03 February 2023 Pages: 3186 - 3187
Absolute Iron Deficiency Anemia Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Nolan M. WinickiIsabella S. FlorissiJonathan B. Greer ASO Research Letter 25 February 2023 Pages: 3188 - 3190
Cancer Stage-Shifting with Sentinel Lymph Node Biopsy in Low-Grade Endometrial Cancer Koji MatsuoAndrew VallejoMaximilian Klar ASO Research Letter 07 March 2023 Pages: 3191 - 3193
Survival for Patients with Radiographically Occult Metastatic Pancreatic Cancer in the Era of Modern Multiagent Chemotherapy Austin M. EckhoffElishama KanuDaniel P. Nussbaum ASO Research Letter 14 March 2023 Pages: 3194 - 3196
A Review of the Current State of Global Surgical Oncology and the Role of Surgeons Who Treat Cancer: Our Profession’s Imperative to Act Upon a Worldwide Crisis in Evolution Aaron C. SaundersMiriam MutebiT. Subramanyeshwar Rao Global Health Services Research Open access 27 March 2023 Pages: 3197 - 3205
The Landmark Series—Ductal Carcinoma in Situ: The Evolution of Treatment Amanda L. NashE. Shelley Hwang Breast Oncology 06 April 2023 Pages: 3206 - 3214
Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers: Outcomes at 70 Months Median Follow-Up Alexandra J. WebsterJulia N. ShannoBarbara L. Smith Breast Oncology 05 January 2023 Pages: 3215 - 3222
ASO Visual Abstract: Oncologic Safety of Nipple-Sparing Mastectomy for Breast Cancer in BRCA Gene Mutation Carriers-Outcomes at 70 Months Median Follow-up Alexandra J. WebsterJulia N. ShannoBarbara L. Smith ASO Visual Abstract 04 April 2023 Pages: 3223 - 3223
The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy may Predict Pathological Complete Response with High Accuracy: Results from a Phase II Trial Ayumi KataokaMasataka SawakiHiroji Iwata Breast Oncology 08 February 2023 Pages: 3224 - 3232
ASO Author Reflections: How Can We Eliminate Breast Surgery in Patients Who Achieved Clinical Complete Response After Neoadjuvant Chemotherapy? Masataka SawakiAyumi Kataoka ASO Author Reflections 10 February 2023 Pages: 3233 - 3234
ASO Visual Abstract: The Absence of Cancer in the Location of a Breast Tissue Marker After Neoadjuvant Chemotherapy May Predict Pathological Complete Response with High Accuracy—Results from a Phase II Trial Ayumi KataokaMasataka SawakiHiroji Iwata ASO Visual Abstract 21 February 2023 Pages: 3235 - 3236
Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomised Controlled Trial Vivian ManDacita SuenAva Kwong Breast Oncology 27 February 2023 Pages: 3237 - 3244
ASO Author Reflections: Pre-Operative Injection of Superparamagnetic Iron Oxide as the Only Localizing Tracer in Sentinel Lymph Node Biopsy in Early Breast Cancer Vivian ManDacita SuenAva Kwong ASO Author Reflections 10 March 2023 Pages: 3245 - 3246
ASO Visual Abstract: Use of Superparamagnetic Iron Oxide (SPIO) Versus Conventional Technique in Sentinel Lymph Node Detection for Breast Cancer: A Randomized Controlled Trial Vivian ManDacita SuenAva Kwong ASO Visual Abstract 30 March 2023 Pages: 3247 - 3247
Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling K. BokkersE. M. A. BleikerM. G. E. M. Ausems Breast Oncology Open access 28 February 2023 Pages: 3248 - 3258
ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients Kyra BokkersMargreet G. E. M. Ausems ASO Author Reflections Open access 24 February 2023 Pages: 3259 - 3260
ASO Visual Abstract: Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling Kyra BokkersEveline M. A. BleikerMargreet G. E. M. Ausems ASO Visual Abstract 27 March 2023 Pages: 3261 - 3262
Preoperative Partial Breast Irradiation in Patients with Low-Risk Breast Cancer: A Systematic Review of Literature Yasmin A. CivilLysanne W. JonkerH. J. G. Desirée van den Bongard Breast Oncology Open access 03 March 2023 Pages: 3263 - 3279
ASO Visual Abstract: Margin Status and Local Recurrence in Phyllodes Tumors of the Breast—A Canadian Series Dan MoldoveanuEricka InyIpshita Prakash Aso Visual Abstract 20 January 2023 Pages: 3280 - 3280
The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from the ACOSOG Z11102 (Alliance) Trial: A Comment Osaid Alser Breast Oncology 01 April 2023 Pages: 3281 - 3281
Reply to: “The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) Trial: A Comment” by Alser, Osaid Karla V. BallmanLinda McCallKari M. Rosenkranz Breast Oncology 27 March 2023 Pages: 3282 - 3283
Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial E. M. F. van de VoortM. FranckenaT. M. A. L. Klem Breast Oncology 10 April 2023 Pages: 3284 - 3285
Correction: Preoperative Immunotherapy Combined with Chemotherapy for Triple-Negative Breast Cancer: Perspective on the KEYNOTE-522 Study Stephanie Downs-CannerElizabeth A. Mittendorf Correction 04 April 2023 Pages: 3286 - 3286
Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer Lisa FrankinetAditi BhattNaoual Bakrin Peritoneal Surface Malignancy 23 February 2023 Pages: 3287 - 3299
ASO Author Reflections: Redefining Consolidation Cytoreductive Surgery for Ovarian Cancer Aditi BhattVincent AlcazerOlivier Glehen ASO Author Reflections 20 February 2023 Pages: 3300 - 3301
ASO Visual Abstract: Role of Hyperthermic Intraperitoneal Chemotherapy Combined with Cytoreductive Surgery as Consolidation Therapy for Advanced Epithelial Ovarian Cancer Lisa FrankinetAditi BhattNaoual Bakrin ASO Visual Abstract 04 April 2023 Pages: 3302 - 3303
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study Florian FangetAmaniel KefleyesusVahan Kepenekian Peritoneal Surface Malignancy 02 February 2023 Pages: 3304 - 3315
ASO Author Reflections: Which is the Optimal Preoperative Systemic Chemotherapy Regimen for Patients with Peritoneal Metastases from Colorectal Cancer? Vahan KepenekianAmaniel KefleyesusOlivier Glehen ASO Author Reflections 08 February 2023 Pages: 3316 - 3317
ASO Visual Abstract: Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes – A Retrospective Study Florian FangetAmaniel KefleyesusVahan Kepenekian ASO Visual Abstract 07 March 2023 Pages: 3318 - 3319
The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases: A Pilot Study Antoine El AsmarPieter DemetterGabriel Liberale Peritoneal Surface Malignancy Open access 08 February 2023 Pages: 3320 - 3328
ASO Author Reflections: Peritoneal Metastases of Colorectal Origin Exhibit Distinct Histological Growth Patterns with a Potential Prognostic Value Antoine El AsmarGabriel Liberale ASO Author Reflections 03 February 2023 Pages: 3329 - 3330
ASO Visual Abstract: The Prognostic Value of Distinct Histological Growth Patterns of Colorectal Peritoneal Metastases—A Pilot Study Antoine El AsmarPieter DemetterGabriel Liberale ASO Visual Abstract 03 March 2023 Pages: 3331 - 3332
Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians Mathew A. KozmanOliver M. FisherDavid L. Morris Peritoneal Surface Malignancy Open access 05 April 2023 Pages: 3333 - 3345
ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians Mathew A. KozmanOliver M. FisherDavid L. Morris Aso Visual Abstract 30 March 2023 Pages: 3346 - 3347
Role of Intraoperative Assessment of Proximal Bile Duct Margin Status and Additional Resection of Perihilar Cholangiocarcinoma: Can Local Clearance Trump Tumor Biology? A Retrospective Cohort Study Fumihiro KawanoHiromichi ItoYu Takahashi Hepatobiliary Tumors 15 February 2023 Pages: 3348 - 3359
ASO Author Reflections: Chasing a Microscopic Cancer-Free Margin During Resection for Perihilar Cholangiocarcinoma: Can Additional Resection Improve the Long-Term Outcomes? Fumihiro KawanoHiromichi ItoYu Takahashi ASO Author Reflections 07 February 2023 Pages: 3360 - 3361
ASO Visual Abstract: Role of Intraoperative Assessment of Proximal Bile Duct Margin Status and Additional Resection of Perihilar Cholangiocarcinoma—Can Local Clearance Trump Tumor Biology? A Retrospective Cohort Study Fumihiro KawanoHiromichi ItoYu Takahashi ASO Visual Abstract 12 March 2023 Pages: 3362 - 3362
TBS-Based Preoperative Score to Predict Non-transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma Henrique A. LimaZorays MoazzamTimothy M. Pawlik Hepatobiliary Tumors 23 February 2023 Pages: 3363 - 3373
ASO Author Reflections: TBS-Based Preoperative Score to Predict Non-Transplantable Recurrence and Identify Candidates for Upfront Resection Versus Transplantation for Hepatocellular Carcinoma Henrique A. LimaZorays MoazzamTimothy M. Pawlik ASO Author Reflections 24 March 2023 Pages: 3374 - 3375
ASO Visual Abstract: TBS-Based Preoperative Score to␣Predict Non-transplantable␣Recurrence and␣Identify Candidates for␣Upfront Resection Versus Transplantation for␣Hepatocellular Carcinoma Henrique A. LimaZorays MoazzamTimothy M. Pawlik ASO Visual Abstract 26 March 2023 Pages: 3376 - 3377
Clinical Significance of Signal Regulatory Protein Alpha (SIRPα) Expression in Hepatocellular Carcinoma Takahiro TomiyamaShinji ItohTomoharu Yoshizumi Hepatobiliary Tumors 15 January 2023 Pages: 3378 - 3389
